Sort by
Refine Your Search
-
Unit at the University of Cambridge provides an ideal place to commence a career in Biostatistics. Our thriving PhD programme is hugely successful and competition for places is high. The BSU's relaxed
-
Science and Technology (CST) at the University of Cambridge. The goal of this PhD programme is to launch one "deceptive by design" project that combines the perspectives of human-computer interaction (HCI) and
-
application of computational tools for the early detection and deconstruction of chromosomal instability in cancer” For further information about the research group, including their most recent publications
-
The Centre for Doctoral Training in Nanoscience and Nanotechnology (NanoDTC) at the University of Cambridge invites applications for its 3.5-year interdisciplinary PhD programme. The programme
-
the computational and experimental methods will be provided in the projects, although relevant previous experience would be advantageous. Applications for this PhD project should be submitted via the University
-
Location: West Cambridge Funder: Tata Steel and the University of Cambridge Duration: 4 years from 1 October 2026 Supervisors: Prof Howard Stone and Dr David Collins Location: The PhD studentship
-
their research findings. Training in all the computational and experimental methods will be provided in the project, although relevant previous experience would be advantageous. Applications for this PhD project
-
The PhD studentship will be based at the University of Cambridge in the Department of Materials Science and Metallurgy as part of the Structural Materials Group. The Structural Materials Group is a
-
technologies, bulk and single-cell RNA-sequencing, flow cytometry, multiplex immunofluorescence, and standard molecular biology and biochemistry techniques. A computational component may also be available
-
Supervisors: Professor Sir Steve Jackson and Dr Mark O'Connor (AZ Partner) Course start date: 1st October 2026 Project details Targeted Alpha Therapy (TAT) selectively delivers high Linear Energy Transfer (LET) alpha-particles to cancer cells, maximising efficacy while minimising toxicity. ...